Cite

HARVARD Citation

    Hong, S. et al. (2021). Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States. Crohn's & colitis 360. 3 (1), p. . [Online]. 
  
Back to record